Media

Media

Recent News

  • Avivagen Secures First Order of OxC-beta™ Livestock in Malaysia

    Ottawa, ON / Business Wire / December 12, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has secured its first order for the use of OxC-beta™ Livestock in Malaysia. The 100-kilogram order quickly follows the recent approval of OxC-beta™ Livestock for use in feed for broilers and swine in the …Read More

  • Avivagen Receives Approval for Use of OxC-beta™ Livestock in Malaysia

    Ottawa, ON / Business Wire / December 5, 2019 / – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has received approval for the use of OxC-beta™ Livestock in Broilers  and Swine in Malaysia. With the addition of Malaysia,  OxC-betaTM Livestock is now approved for use in eight markets worldwide, including the United …Read More

  • Avivagen Attends 5th Annual Torrey Hills Capital Emerging Growth Conference in Rancho Santa Fe, California

    Ottawa, ON, November 22, 2019: – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it presented at the 5th Annual Torrey Hills Capital Emerging Growth Conference on November 21, 2019. The conference, which is by invitation only, was the first time Avivagen presented to a U.S. West Coast investor audience. Kym Anthony, CEO, and …Read More

  • Avivagen Secures Third Major OxC-beta™ Livestock Order in Asia-Pacific

    UNAHCO seeks to expand use of OxC-BetaTM Livestock with new application in Broilers, creating new market opportunity for expanded use in a wide variety of feeds worldwide Ottawa, ON/ Business Wire/ November 12, 2019: – Avivagen Inc. (TSXV:VIV) (“Avivagen”) is pleased to announce that it has secured another substantial order for 2.1 metric tons of …Read More

  • Avivagen Share Issue

    Ottawa, ON /Business Wire/ November 11, 2019 / Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance, announces that it will issue 80,645  common shares pursuant to a previously …Read More

View All News Releases

Media Coverage

  • VICTAM Asia

    Avivagen CEO Interviewed at VICTAM Asia 2018 Conference

    Avivagen recently debuted at the VICTAM ASIA 2018 Conference in Bangkok, Thailand.

  • CEO Kym Anthony Interviewed by Uptick

    CEO Kym Anthony was interviewed by the penny stock news and trends podcast, Uptick Newswire.

    I think if people keep their eyes on the size of the prize, [they’ll see] the livestock market is in the billions of dollars; our share of that would be in the hundreds of millions if we roll out successfully. The human market is untouched. The companion animal market is also big. We’ve spent years proving it works; everyone agrees it works. Now is the time to roll it out commercially.

  • CTV: Growing resistance to antibiotics fuels market for alternative solutions

    CTV NEWS, TORONTO – A hundred years ago, a small wound could result in death if an infection spread. That could become reality again as the world threatens to return to a pre-antibiotic era due to antibiotic resistance.

    Some have pointed to the widespread use of antibiotics in livestock feed as a culprit, resulting in urgent calls to quell their use and find alternatives.

View All Media Coverage